Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Operations (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Cash from Operations for 15 consecutive years, with 1937554.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 0.61% to 1937554.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5856445.0 through Dec 2025, down 10.47% year-over-year, with the annual reading at 5856445.0 for FY2025, 10.47% down from the prior year.
  • Cash from Operations for Q4 2025 was 1937554.0 at Creative Medical Technology Holdings, down from 1168609.0 in the prior quarter.
  • The five-year high for Cash from Operations was 222139.0 in Q2 2021, with the low at 3841642.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 1459918.5, with a median of 1236566.0 recorded in 2023.
  • The sharpest move saw Cash from Operations plummeted 2137.93% in 2021, then skyrocketed 76.65% in 2024.
  • Over 5 years, Cash from Operations stood at 1161336.0 in 2021, then tumbled by 209.23% to 3591234.0 in 2022, then soared by 47.23% to 1894983.0 in 2023, then dropped by 2.88% to 1949536.0 in 2024, then grew by 0.61% to 1937554.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1937554.0, 1168609.0, and 1158747.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.